课题基金 / 基金详情

Total Synthesis of Biologically Active Gamma-Pyrones

Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
批准号:
6890272
负责人:
DIRK HARTWIG TRAUNER
金额:
$23.91万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-02 至 2008-04-30

项目摘要

项目成果

DIRK HARTWIG TRAUNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Total syntheses of the immunosuppressants SNF4435 C and D as well as the antibiotics spectinabilin and N-acetyl aureothamine are proposed. These highly unsaturated polypropionates were isolated from various strains of Streptomyces sp. Furthermore, synthetic approaches towards the molluscan polypropionates photodeoxytridachione and crispatene as well as the fungal immunosuppressants candelalide A and B are presented. All natural products feature a terminal gamma-pyrone moiety as a common structural motif. Polyenes consisting of an array of conjugated trisubstituted double bonds have been used as synthetic precursors of the complex polypropionates. The stereoselective assembly of these structures will be further investigated. Preliminary studies have shown that the core bicyclo[4.2.0]octadiene core of SNF4435 compounds can be formed using a highly stereoselective tandem Stille cross-coupling / electrocyclization cascade. A novel Lewis-acid catalyzed cyclization leading to the bicyclo[3.1.0]hexane core of photodeoxytridachione and crispatene has also been developed. The proposed total syntheses provide an opportunity to investigate asymmetric electrocyclization reactions. As opposed to cycloadditions and sigmatropic rearrangements, this class of pericyclic reactions has not yet succumbed to asymmetric catalysis. In a further contribution to synthetic methodology, new approaches towards gamma-pyrones are proposed. The significance of the gamma-pyrone moiety for the biological activity of the natural products will be explored. The biological mode of action of SNF4435C and D remains presently unknown. The natural products do not suppress IL-2 production, distinguishing them from FK506 or cyclosporin A. Our synthetic material and derivatives thereof will be used to isolate binding proteins and gain further insight into of the mechanism of these promising new lead compounds for drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optical Control of the Actin Cytoskeleton
  • 批准号:
    10736022
  • 项目类别:
  • 资助金额:
    $32.72万
  • 财政年份:
    2018
  • 负责人:
    DIRK HARTWIG TRAUNER
  • 依托单位:
Merocytochalasans, Photocytochalasans and the Optical Control of the Actin Cytoskeleton
  • 批准号:
    9920728
  • 项目类别:
  • 资助金额:
    $26.57万
  • 财政年份:
    2018
  • 负责人:
    DIRK HARTWIG TRAUNER
  • 依托单位:
Merocytochalasans, Photocytochalasans and the Optical Control of the Actin Cytoskeleton
  • 批准号:
    9752602
  • 项目类别:
  • 资助金额:
    $26.6万
  • 财政年份:
    2018
  • 负责人:
    DIRK HARTWIG TRAUNER
  • 依托单位:
Molecular Recognition of Potassium Channels
  • 批准号:
    7058256
  • 项目类别:
  • 资助金额:
    $25.56万
  • 财政年份:
    2004
  • 负责人:
    DIRK HARTWIG TRAUNER
  • 依托单位:
国内基金
海外基金
Streptomyces rochei D21E05 次级代谢产物分离纯化及其活性功能研究
Streptomyces rimosus M527特异性高强度合成龟裂霉素的多模块协同改造
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    马正
  • 依托单位:
深海放线菌Streptomyces sp. 11695的抗菌活性次级代谢产物基因组挖掘
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    罗明和
  • 依托单位:
基于TAG途径解析 Streptomyces exfoliates A1013Y中蓝色素代谢调控分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    朱运平
  • 依托单位: